Stage TNM 5-year Survival Cases
0 Carcinoma in situ    
IA T1N0M0 67% [1], [2]
IB T2N0M0 57% [1]
IIA T1N1M0 55% [1]
IIB T2N1M0
T3N0M0
38% [1]
IIIA T3N1M0
T1N2M0
T2-3N2M0
23% [1]
IIIB T4N0-2
T1-4N3M0
5% [1], [2]
IV T1-4N0-3M1 1% [1], [2]